ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 130 filers reported holding ACCELERON PHARMA INC in Q1 2016. The put-call ratio across all filers is 3.66 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $237,000 | +33.1% | 1,372 | -2.5% | 0.01% | +25.0% |
| Q2 2021 | $178,000 | -7.3% | 1,407 | -0.4% | 0.00% | 0.0% |
| Q1 2021 | $192,000 | +23.1% | 1,413 | +15.6% | 0.00% | -33.3% |
| Q4 2020 | $156,000 | +32.2% | 1,222 | +15.0% | 0.01% | -14.3% |
| Q3 2020 | $118,000 | – | 1,063 | – | 0.01% | – |
| Q2 2020 | $0 | – | 0 | -100.0% | 0.00% | – |
| Q4 2018 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q3 2018 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q2 2018 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q1 2018 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q4 2017 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q3 2017 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q2 2017 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q1 2017 | $0 | -100.0% | 6 | -71.4% | 0.00% | – |
| Q4 2016 | $1,000 | 0.0% | 21 | 0.0% | 0.00% | – |
| Q3 2016 | $1,000 | 0.0% | 21 | +40.0% | 0.00% | – |
| Q2 2016 | $1,000 | -50.0% | 15 | -53.1% | 0.00% | – |
| Q4 2015 | $2,000 | – | 32 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 1,400,000 | $133,378,000 | 3.73% |
| Foresite Capital Management III, LLC | 42,030 | $4,004,000 | 3.56% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 257,249 | $24,508,000 | 2.23% |
| Cormorant Asset Management, LP | 600,000 | $57,162,000 | 2.18% |
| Avoro Capital Advisors LLC | 1,040,000 | $99,081,000 | 1.96% |
| QVT Financial LP | 101,396 | $9,660,000 | 1.64% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,100,000 | $200,067,000 | 1.60% |
| Rhenman & Partners Asset Management AB | 155,000 | $14,767,000 | 1.60% |
| Parkman Healthcare Partners LLC | 57,500 | $5,478,000 | 1.54% |
| Ikarian Capital, LLC | 187,700 | $17,882,000 | 1.42% |